CSI Market
Sign In | Register

Enlivex Therapeutics Ltd (ENLV) Annual Balance Sheets

Annual · GAAP · USD millions
Access ENLV quarterly Balance Sheets →
The balance sheet data below highlights changes in Enlivex Therapeutics Ltd's financial position over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent1.58
Cash, Cash Equivalents Other0.00
Marketable Securities, Current SH0.00
Other Short-term Investments AS3.86
Cash & Short-term Investments4.00
Other Receivables, Net, Current0.24
Notes Receivable, Current0.16
Inventories0.00
Discontinued Operations0.00
Other Current Assets1,733.06
Prepaid Expense And Other Assets Current4.36
Total Current Assets1,743.18
Equipment/Property/Plant Net3.31
Long-term investments2.37
Financial Instruments0.01
Tax Assets, Noncurrent2.24
Prepaid Expense, Noncurrent, Total PR0.00
Other Assets, Noncurrent583.46
Receivables Held For Sale Amount-
Crypto Asset Fair Value Current24.27
Digital Assets Purchase Option1,708.79
Total Assets2,327.00
Liabilities
Accounts Payable, Trade, Current3.81
Accrued Liabilities, Current AC5.21
Short-term Debt0.00
Other Liabilities, Current0.00
Taxes Payable0.00
Total Current Liabilities9.02
Other Long-term Debt LO0.00
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent382.65
Asset Retirement Obligations, Noncurrent AS0.00
Other liabilities, Noncurrent0.00
Liability Held For Sale Current-
Deferred Income Tax Liabilities Net382.65
Operating Lease Liability Noncurrent0.38
Total Liabilities392.05
Stockholders' Equity
Common Stock Value28.73
Additional Paid In Capital Common Stock796.70
Retained Earnings / Accumulated Deficit1,108.42
Accumulated Other Comprehensive Income1.10
Other Equity1.10
Common Stockholder's Equity1,934.95
Total Stockholder's Equity1,934.95
Liabilities & Stockholder's Equity2,327.00
4 historic quarters locked

Sign in to unlock the full Enlivex Therapeutics Ltd balance sheet history.

Sign In Create Free Account

About Enlivex Ltd Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-033857

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License